Home Articles

Articles

Welcome to the ARCHIVE of Pharma Marketing News articles. All articles are FREE! No subscription is required to download these articles from past issues. Articles become available to non-subscribers approximately two months after publication. To obtain articles as soon as they are published, you must subscribe to the email newsletter service. Subscription is free and supported by advertising.

The iPad in the Doctor’s Office

The Apple iPad has also become a

A Tale of Two Pharma Whistleblower Novels

Big Pharma and Killer Drug

Pharma Marketing News Vol. 9, #6: Summer 2010

Welcome to the SUMMER 2010 issue of Pharma Marketing News.

Pharma Marketing News Vol. 13, No. 3: March 2014

Welcome to Volume 13, Issue #3 (March 2014) of Pharma Marketing News.

Orphan Drugs Now “Where the Money Is,” Says Willie Sutton’s Ghost

Why do pharma companies bother developing drugs for for a disorder affecting fewer than 200,000 people? Willie Sutton's ghost may have the answer.

The Future of Pharma Marketing is Mobile, Unless…: …FDA’s “Enforcement Discretion” Remains Unclear

You don't need a crystal ball to know that the future of media is mobile. While pharmaceutical companies may not yet be advertising on mobile devices as they do on TV, websites, and magazines, they are developing health apps that run on Droid smartphones, iPhones and iPads. Many observers feel that the pharma industry lags behind other industries as far as having a mobile strategy is concerned. One of the factors that may be holding back pharma in its pursuit of a mobile strategy is the loomimg sepecter of FDA regulations.

Closed-Loop Patient Education: MedTera and HealthPrize Team Up to Improve Medication Adherence & Health...

MedTera recently partnered with HealthPrize Technologies, a web-based software company that motivates people to fill and stay on prescription medications, to bring together MedTera's online and offline educational resources and HealthPrize's online, interactive platform to educate people about their chronic diseases and incentivize them for taking their medications as prescribed.

Pfizer Battles to Protect Lipitor Cash Cow

Lipitor Won't Go Gentle Into that Good Generic Night. Pfizer is taking a number of steps to protect it's Lipitor franchise and it hopes that many patients currently taking Lipitor will remain loyal to the brand.

OpEd: Spam spam spam spam. Lovely spam! Wonderful spam!

Whatever your opinion of the CAN-SPAM law and blacklists, a bright light is now focused on the spam e-mail problem. As usual, those e-mail marketers who want to obey the law have to jump through new hoops and change their business practices. Meanwhile, the real spammers will no doubt continue to outfox the regulatory agencies, attorneys general, and the ISPs and continue to spew spam at will.

FDA’s Good Reprint Practices Guidance

Medical journals may soon become the pharmaceutical industry's newest physician marketing partner. This article summarizes some of the pros and cons of FDA's Good Reprint Practices Guidance and presents preliminary results of a reader survey on the topic.

Pharma Marketing News, Blog Posts, Events, Podcasts

- Advertisement -